TFRC and myeloid sarcoma: The frequencies of CXCR5+CD25+PD-1+Foxp3+/CD127− or CXCR5+CD25hi/+ CD127dim/− Tfr cells were decreased significantly and exhibited reduced suppressive capacity in blood and CSF of MS patients (85–87, 89).